These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 18024234)
1. Drug induced superinfection in HIV and the evolution of drug resistance. Leontiev VV; Maury WJ; Hadany L Infect Genet Evol; 2008 Jan; 8(1):40-50. PubMed ID: 18024234 [TBL] [Abstract][Full Text] [Related]
2. Regulated superinfection may help HIV adaptation on rugged landscape. Leontiev V; Hadany L Infect Genet Evol; 2010 May; 10(4):505-10. PubMed ID: 20226882 [TBL] [Abstract][Full Text] [Related]
3. Recombination in HIV and the evolution of drug resistance: for better or for worse? Bretscher MT; Althaus CL; Müller V; Bonhoeffer S Bioessays; 2004 Feb; 26(2):180-8. PubMed ID: 14745836 [TBL] [Abstract][Full Text] [Related]
4. Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy. Di Giambenedetto S; Zazzi M; Corsi P; Gonnelli A; Di Pietro M; Giacometti A; Almi P; Trezzi M; Boeri E; Gianotti N; Menzo S; Del Gobbo R; Francisci D; Nerli A; Galli L; De Luca A; Antivir Ther; 2009; 14(3):359-69. PubMed ID: 19474470 [TBL] [Abstract][Full Text] [Related]
5. HIV-1 intra-subtype superinfection rates: estimates using a structured coalescent with recombination. Taylor JE; Korber BT Infect Genet Evol; 2005 Jan; 5(1):85-95. PubMed ID: 15567142 [TBL] [Abstract][Full Text] [Related]
6. HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo. Martinez-Picado J; Martínez MA Virus Res; 2008 Jun; 134(1-2):104-23. PubMed ID: 18289713 [TBL] [Abstract][Full Text] [Related]
7. Intra-host evolution of human immunodeficiency virus type 1 and viral fitness. Clementi M; Canducci F; Bagnarelli P; Menzo S New Microbiol; 2004 Apr; 27(2 Suppl 1):41-4. PubMed ID: 15646063 [TBL] [Abstract][Full Text] [Related]
8. Estimation of an in vivo fitness landscape experienced by HIV-1 under drug selective pressure useful for prediction of drug resistance evolution during treatment. Deforche K; Camacho R; Van Laethem K; Lemey P; Rambaut A; Moreau Y; Vandamme AM Bioinformatics; 2008 Jan; 24(1):34-41. PubMed ID: 18024973 [TBL] [Abstract][Full Text] [Related]
9. Multidrug-resistant variants of HIV type 1 (HIV-1) can exist in cells as defective quasispecies and be rescued by superinfection with other defective HIV-1 variants. Quan Y; Liang C; Brenner BG; Wainberg MA J Infect Dis; 2009 Nov; 200(9):1479-83. PubMed ID: 19758098 [TBL] [Abstract][Full Text] [Related]
10. Combination antiretroviral therapy failure and HIV super-infection. Bezemer D; van Sighem A; de Wolf F; Cornelissen M; van der Kuyl AC; Jurriaans S; van der Hoek L; Prins M; Coutinho RA; Lukashov VV AIDS; 2008 Jan; 22(2):309-11. PubMed ID: 18097235 [TBL] [Abstract][Full Text] [Related]
11. Characterization of HIV-1 subtypes and viral antiretroviral drug resistance in men who have sex with men in Beijing, China. Zhang X; Li S; Li X; Li X; Xu J; Li D; Ruan Y; Xing H; Zhang X; Shao Y AIDS; 2007 Dec; 21 Suppl 8():S59-65. PubMed ID: 18172393 [TBL] [Abstract][Full Text] [Related]
12. HIV-1 drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy. Sungkanuparph S; Apiwattanakul N; Thitithanyanont A; Chantratita W; Sirinavin S Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):83-8. PubMed ID: 19323038 [TBL] [Abstract][Full Text] [Related]
13. Opinion paper. Resistance to new anti-HIV agents: problems in the pathway of drug registration. Dalmau D; Klimkait T; Telenti A Antivir Ther; 2005; 10(7):867-72. PubMed ID: 16312184 [TBL] [Abstract][Full Text] [Related]
14. Low rate of emergence of nevirapine and lamivudine resistance after post-partum interruption of a triple-drug regimen. Pérez H; Vignoles M; Laufer N; Gómez A; Coll P; Lottner J; Rolón M; Salomón H; Cahn P Antivir Ther; 2008; 13(1):135-9. PubMed ID: 18389908 [TBL] [Abstract][Full Text] [Related]
15. Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study. Cozzi-Lepri A; Phillips AN; Clotet B; Mocroft A; Ruiz L; Kirk O; Lazzarin A; Wiercinska-Drapalo A; Karlsson A; Lundgren JD; AIDS; 2008 Oct; 22(16):2187-98. PubMed ID: 18832882 [TBL] [Abstract][Full Text] [Related]
16. Evolution of HIV-1 in a patient population failing multiple-drug therapy. Hong S; Cao J; Tu YT Microbiol Immunol; 2009 Sep; 53(9):535-9. PubMed ID: 19703248 [TBL] [Abstract][Full Text] [Related]
17. HIV-1-resistant strains during 8-week on 8-week off intermittent therapy and their effect on CD4+ T-cell counts and antiviral response. Izopet J; Marchou B; Charreau I; Sauné K; Tangre P; Molina JM; Aboulker JP; Antivir Ther; 2008; 13(4):537-45. PubMed ID: 18672532 [TBL] [Abstract][Full Text] [Related]
18. [HIV superinfection: clinical and biological implications]. Valer L; de Mendoza C; Soriano V Med Clin (Barc); 2003 Jul; 121(5):192-6. PubMed ID: 12867008 [TBL] [Abstract][Full Text] [Related]
19. Update of the Drug Resistance Mutations in HIV-1. Johnson VA; Brun-Vezinet F; Clotet B; Gunthard HF; Kuritzkes DR; Pillay D; Schapiro JM; Richman DD Top HIV Med; 2008 Dec; 16(5):138-45. PubMed ID: 19106428 [TBL] [Abstract][Full Text] [Related]
20. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Hirsch MS; Günthard HF; Schapiro JM; Brun-Vézinet F; Clotet B; Hammer SM; Johnson VA; Kuritzkes DR; Mellors JW; Pillay D; Yeni PG; Jacobsen DM; Richman DD Clin Infect Dis; 2008 Jul; 47(2):266-85. PubMed ID: 18549313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]